Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study

This paper presents the results of an observational and retrospective study on the therapeutic effects of Jusvinza, an immunomodulatory peptide with anti-inflammatory properties for critically ill COVID-19 patients. This peptide induces regulatory mechanisms on the immune response in experimental sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Venegas-Rodríguez, Rafael, Serrano-Díaz, Anabel, Peña-Ruiz, Ruben, Santana-Sánchez, Raul, Hernández-Cedeño, Mabel, Rittoles Navarro, Aliusha, Grecesqui-Cruz, Inti, Pérez-Aguilera, Liam, Segura-Fernández, Anadys, Rosario-Cruz, Leticia, Martínez-Donato, Gilliam, Guillén-Nieto, Gerardo, Domínguez- Horta, Maria del Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894446/
https://www.ncbi.nlm.nih.gov/pubmed/36730325
http://dx.doi.org/10.1371/journal.pone.0281111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894446/
https://www.ncbi.nlm.nih.gov/pubmed/36730325
http://dx.doi.org/10.1371/journal.pone.0281111

Ejemplares similares